Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $80.0000 (-3.61%) ($80.0000 - $81.0000) on Wed. Apr. 2, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 11.42% (three month average) | RSI | 27 | Latest Price | $80.0000(-3.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1% a day on average for past five trading days. | Weekly Trend | CAPR declines -16.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(7%) JNK(7%) PEJ(7%) SPY(7%) VT(7%) | Factors Impacting CAPR price | CAPR will decline at least -5.71% in a week (0% probabilities). TLT(-3%) UUP(-2%) DIA(-2%) SHY(-1%) GLD(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.71% (StdDev 11.42%) | Hourly BBV | 0 () | Intraday Trend | -1.2% | | | |
|
1 - 5 Day Possible Target | $56.7(-29.13%) | Resistance Level | $101.24 | 5 Day Moving Average | $79.9(0.13%) | 10 Day Moving Average | $86.94(-7.98%) | 20 Day Moving Average | $101.24(-20.98%) | To recent high | -48.4% | To recent low | 135.3% | Market Cap | $1.576b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |